The Board Considered 15% dividend on its Board Meeting held on 29th May,2026. Nitin S.Shah
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.1 pts more than Nifty Microcap 250 and 12.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Crestchem Limited's board, meeting on May 29, 2026 (rescheduled from May 26 for non-quorum), approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of Rs. 1.50 per equity share (15%) on the Rs. 10 face value for FY2025-26, subject to shareholder approval at the 34th AGM. The company also formed a new subsidiary, Oleo Biosciences Private Limited, in Bangalore (Crestchem holds 75%), and approved an investment of up to Rs. 2.25 crore in it. Profit for FY26 stood at Rs. 375.74 lakhs versus Rs. 365.68 lakhs in FY25, with total assets rising sharply to Rs. 1,628.92 lakhs from Rs. 1,054.48 lakhs. Reappointments of three directors for five-year terms were also approved.
Shareholders will receive a Rs. 1.50 per share dividend pending AGM approval, while the company signals expansion into a new subsidiary business (biosciences). Strong growth in assets and operating cash flow (Rs. 409.22 lakhs vs Rs. 185 lakhs) suggests improving business health, which may be viewed positively by investors.